Αρχειοθήκη ιστολογίου

Τρίτη 25 Ιουλίου 2017

FDA Grants Full Approval to Blinatumomab for Acute Lymphoblastic Leukemia

FDA changed its accelerated approval of blinatumomab (Blincyto) for some patients with acute lymphoblastic leukemia to a full approval and expanded the approved indications for its use.



from # & - All via ola Kala on Inoreader http://ift.tt/2eLwAGN

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου